The DOI matches its Crossref record; 324 of the 324 references it cites were found in a registry or an index.
Cannabinoids and Epilepsy
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–324 of 324
Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation
Cahill, K., & USSHER, M. H. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005353.pub2 · Cited by 114
The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice
Shafaroodi, H., Samini, M., Moezi, L., Homayoun, H., Sadeghipour, H., Tavakoli, S., Hajrasouliha, A. R., & Dehpour, A. R. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.04.011 · Cited by 112
Effect of cannabidiol and of other Cannabis sativa compounds on hippocampal seizure discharges
Izquierdo, I., Orsingher, O. A., & Berardi, A. C. (1973) · Psychopharmacology · doi:10.1007/bf00413961 · Cited by 111
Anandamide suppresses nitric oxide and TNF-α responses to Theilerʼs virus or endotoxin in astrocytes
Molina‐Holgado, F., Lledó, A., & Guaza, C. (1997) · Neuroreport · doi:10.1097/00001756-199705260-00027 · Cited by 110
Anticonvulsant Nature of Marihuana Smoking
Consroe, P. F. (1975) · JAMA · doi:10.1001/jama.1975.03260160054015 · Cited by 110
Zhuang, S.-Y., Kittler, J. T., Grigorenko, E. V., Kirby, M. T., Sim, L. J., Hampson, R. E., Childers, S. R., & Deadwyler, S. A. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00232-0 · Cited by 110
The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs
Rogawski, M. A. (2013) · Epilepsia · doi:10.1111/epi.12182 · Cited by 110
Treatment of Lennox-Gastaut syndrome: overview and recent findings
van Rijckevorsel, K. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s1668 · Cited by 108
Wyeth, M. S., Zhang, N., Módy, I., & Houser, C. R. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1183-10.2010 · Cited by 107
McKinney, D. L., Cassidy, M. P., Collier, L., Martin, B. R., Wiley, J. L., Selley, D. E., & Sim‐Selley, L. J. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.130328 · Cited by 106
Leite, J. R., & Carlini, E. A. (1974) · Psychopharmacology · doi:10.1007/bf00421785 · Cited by 102
Crippa, J. A. S., Hallak, J. E. C., Machado-de-Sousa, J. P., Queiroz, R. H. C., Bergamaschi, M., Chagas, M. H. N., & Zuardi, A. W. (2013) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12018 · Cited by 101
Karanian, D. A., Karim, S. L., Wood, J. T., Williams, J. S., Lin, S., Makriyannis, A., & Bahr, B. A. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.120147 · Cited by 98
Fan, F., Tao, Q., Abood, M. E., & Martin, B. R. (1996) · Brain Research · doi:10.1016/0006-8993(95)01113-7 · Cited by 97
Echegoyen, J. C., Armstrong, C., Morgan, R. J., & Soltész, I. (2009) · Epilepsy Research · doi:10.1016/j.eplepsyres.2009.02.019 · Cited by 95
Δ9-Tetrahydrocannabinol protects hippocampal neurons from excitotoxicity
Gilbert, G. L., Kim, H. J., Waataja, J. J., & Thayer, S. A. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.011 · Cited by 94
Guggenhuber, S., Monory, K., Lutz, B., & Klugmann, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015707 · Cited by 93
Robson, P. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2011.575778 · Cited by 93
Szabo, G. G., Lenkey, N., Holderith, N. B., Andrási, T., Nusser, Z., & Hájos, N. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0247-14.2014 · Cited by 93
Cannabinoids inhibit the synaptic uptake of adenosine and dopamine in the rat and mouse striatum.
Pandolfo, P., Silveirinha, V., Santos-Rodrigues, A. D., Venance, L., Ledent, C., Takahashi, R. N., Cunha, R., & Köfalvi, A. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.01.013 · Cited by 92
Bhaskaran, M. D., & Smith, B. N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010683 · Cited by 91
Gross, D. W., Hamm, J., Ashworth, N. L., & Quigley, D. G. (2004) · Neurology · doi:10.1212/01.wnl.0000127623.03766.75 · Cited by 91
Acute intoxication by synthetic cannabinoids – Four case reports
Hermanns‐Clausen, M., Kneisel, S., Hutter, M., Szabó, B., & Auwärter, V. (2013) · Drug Testing and Analysis · doi:10.1002/dta.1483 · Cited by 90
Falenski, K. W., Carter, D. S., Harrison, A. J., Martin, B. R., Blair, R. E., & DeLorenzo, R. J. (2009) · Brain Research · doi:10.1016/j.brainres.2009.01.036 · Cited by 88
Anticonvulsant effect of cannabidiol.
Fr, A., & Cridland, S. (1986) · PubMed · Cited by 88
Hayakawa, K., Mishima, K., Nozako, M., Hazekawa, M., Irie, K., Fujioka, M., Orito, K., Abe, K., Hasebe, N., Egashira, N., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04565.x · Cited by 87
Vilela, L., Medeiros, D. D. C., Rezende, G. H. D. S. E., de Oliveira, A. C. P., Moraes, M. F. D., & Moreira, F. A. (2013) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.11.006 · Cited by 86
Abood, M. E., Sauss, C., Fan, F., Tilton, C. L., & Martin, B. R. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90546-6 · Cited by 85
CHESHER, G. B., & Jackson, D. M. (1974) · Psychopharmacology · doi:10.1007/bf00421539 · Cited by 84
Manna, S. S. S., & Umathe, S. N. (2012) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.02.003 · Cited by 84
Endocannabinoids block status epilepticus in cultured hippocampal neurons
Deshpande, L. S., Blair, R. E., Ziobro, J. M., Sombati, S., Martin, B. R., & DeLorenzo, R. J. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.11.030 · Cited by 84
McQuade, D., Hudson, S. C., Dargan, P. I., & Wood, D. M. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1379-2 · Cited by 83
The Therapeutic Potential Of Marihuana
Cohen, S., & Stillman, R. C. (1976) · Springer eBooks · doi:10.1007/978-1-4613-4286-1 · Cited by 82
Falenski, K. W., Blair, R. E., Sim‐Selley, L. J., Martin, B. R., & DeLorenzo, R. J. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.01.065 · Cited by 82
Dynamic changes of CB1‐receptor expression in hippocampi of epileptic mice and humans
Maglóczky, Z., Tóth, K., Karlócai, M. R., Nagy, S., Erőss, L., Czirják, S., Vajda, J., Rásonyi, G., Kelemen, A., Juhos, V., et al. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02624.x · Cited by 81
Photowala, H., Blackmer, T., Schwartz, E., Hamm, H. E., & Alford, S. T. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600509103 · Cited by 81
The Therapeutic Use of Cannabis sativa (L.) in Arabic Medicine
Lozano, I. (2001) · Journal of Cannabis Therapeutics · doi:10.1300/j175v01n01_05 · Cited by 81
Jacobus, J., Squeglia, L. M., Sorg, S. F., Nguyen‐Louie, T. T., & Tapert, S. F. (2014) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2014.75.729 · Cited by 79
Crane, N. A., Schuster, R. M., & González, R. (2013) · Journal of the International Neuropsychological Society · doi:10.1017/s135561771300088x · Cited by 79
Karlócai, M. R., Tóth, K., Watanabe, M., Ledent, C. A., Juhász, G. D., Freund, T. F., & Maglóczky, Z. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027196 · Cited by 76
Selective Antiepileptic Effects ofN‐Palmitoylethanolamide, a Putative Endocannabinoid
Sheerin, A. H., Zhang, X., Saucier, D. M., & Corcoran, M. E. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.16604.x · Cited by 76
Isolation of Cannabinol, Cannabidiol and Quebrachitol from Red Oil of Minnesota Wild Hemp
ADAMS, R. L. P., Pease, D. C., & Clark, J. H. (1940) · Journal of the American Chemical Society · doi:10.1021/ja01865a080 · Cited by 76
Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats
Colasanti, B. K., Lindamood, C., & Craig, C. R. (1982) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(82)90418-x · Cited by 73
Combined cannabinoid therapy via an oromucosal spray
Pérez, J. (2006) · Drugs of today · doi:10.1358/dot.2006.42.8.1021517 · Cited by 73
Guy, G. W., & Robson, P. (2004) · Journal of Cannabis Therapeutics · doi:10.1300/j175v03n04_01 · Cited by 73
Tolerance to marijuana: Heart rate and subjective “high”
Nowlan, R., & Cohen, S. (1977) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1977225part1550 · Cited by 73
Shirazi-zand, Z., Ahmad-Molaei, L., Motamedi, F., & Naderi, N. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.03.009 · Cited by 71
Blair, R. E., Deshpande, L. S., Sombati, S., Elphick, M. R., Martin, B. R., & DeLorenzo, R. J. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.007 · Cited by 69
Adolescent Cannabinoid Exposure Permanently Suppresses Cortical Oscillations in Adult Mice
Raver, S. M., Haughwout, S. P., & Keller, A. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.164 · Cited by 69
Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation
Cahill, K., & USSHER, M. H. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005353.pub3 · Cited by 69
Experimental Models of Seizures and Epilepsies
Raol, Y. H., & Brooks‐Kayal, A. R. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394596-9.00003-2 · Cited by 68
Corchero, J., Romero, J., Berrendero, F., Fernández‐Ruíz, J., Ramos, J. A., Fuentes, J. A., & Manzanares, J. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00053-4 · Cited by 67
Effects of cannabis on cognition in patients with MS
Pavisian, B., MacIntosh, B. J., Szilagyi, G., Staines, R. W., O'Connor, P. W., & Feinstein, A. (2014) · Neurology · doi:10.1212/wnl.0000000000000446 · Cited by 66
Naidoo, V., Karanian, D. A., Vadivel, S. K., Locklear, J. R., Wood, J. T., Nasr, M. L., Quizon, P. M., Graves, E. E., Shukla, V. G., Makriyannis, A., et al. (2012) · Neurotherapeutics · doi:10.1007/s13311-011-0100-y · Cited by 65
Responses to Oral Δ9-Tetrahydrocannabinol in Frequent and Infrequent Marijuana Users
Kirk, J. M., & de Wit, H. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00264-0 · Cited by 65
Characterization of cannabidiol-mediated cytochrome P450 inactivation
Bornheim, L. M., Everhart, E. T., Li, J., & Correia, M. A. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90286-6 · Cited by 64
Antiepileptic and Prophylactic Effects of Tetrahydrocannabinols in Amygdaloid Kindled Rats
Corcoran, M. E., McCaughran, J. A., & Wada, J. (1978) · Epilepsia · doi:10.1111/j.1528-1157.1978.tb05011.x · Cited by 63
Citraro, R., Russo, E., Ngomba, R. T., Nicoletti, F., Scicchitano, F., Whalley, B. J., Calignano, A., & Sarro, G. D. (2013) · Epilepsy Research · doi:10.1016/j.eplepsyres.2013.06.004 · Cited by 63
Self-citationDouble-blind clinical study of cannabidiol as a secondary anticonvulsant
Trumbly, B. (1990) · Medical Entomology and Zoology · Cited by 63
Łuszczki, J. J., Czuczwar, P., Cioczek‐Czuczwar, A., & Czuczwar, S. J. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.07.037 · Cited by 62
Kozan, R., Ayyıldız, M., & Ağar, E. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02098.x · Cited by 62
Cabral, G. A., Harmon, K. W. N., & Carlisle, S. J. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-47611-8_24 · Cited by 61
Internet Highs—Seizures After Consumption of Synthetic Cannabinoids Purchased Online
Tofighi, B., & Lee, J. D. (2012) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e3182619004 · Cited by 61
Naderi, N., Ahari, F. A., Shafaghi, B., Najarkolaei, A. H., & Motamedi, F. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0076-x · Cited by 59
van Rijn, C. M., Gaetani, S., Santolini, I., Badura, A., Gabova, A., Fu, J. X., Watanabe, M., Cuomo, V., van Luijtelaar, G., Nicoletti, F., et al. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02510.x · Cited by 59
Cannabis and other illicit drug use in epilepsy patients
Hamerle, M., Ghaeni, L., Kowski, A. B., Weissinger, F., & Holtkamp, M. (2013) · European Journal of Neurology · doi:10.1111/ene.12081 · Cited by 58
The effects of Δ9-tetrahydrocannabinol physical dependence on brain cannabinoid receptors
Breivogel, C. S., Scates, S. M., Beletskaya, I. O., Lowery, O. B., Aceto, M. D. G., & Martin, B. R. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02854-6 · Cited by 56
SUBACUTE CANNABINOID TREATMENT: ANTICONVULSANT ACTIVITY AND WITHDRAWAL EXCITABILITY IN MICE
Karler, R., & Turkanis, S. A. (1980) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1980.tb14562.x · Cited by 56
Complex partial seizure symptoms affected by marijuana abuse.
Ellison, J. M., Gelwan, E., & Ogletree, J. N. (1990) · PubMed · Cited by 54
Turkanis, S. A., Smiley, K. A., Borys, H. K., Olsen, D. M., & Karler, R. (1979) · Epilepsia · doi:10.1111/j.1528-1157.1979.tb04815.x · Cited by 53
Modulation of Pilocarpine-Induced Seizures by Cannabinoid Receptor 1
Kow, R. L., Jiang, K., Naydenov, A. V., Le, J. H., Stella, N., & Nathanson, N. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095922 · Cited by 53
Grand mal convulsions subsequent to marijuana use. Case report.
KEELER, M. H., & Reifler, C. B. (1967) · PubMed · Cited by 52
On the application of cannabis in paediatrics and epileptology.
Lorenz, R. (2004) · PubMed · Cited by 52
Rimmerman, N., Juknat, A., Kozela, E., Levy, R., Bradshaw, H. B., & Vogel, Z. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9692-3 · Cited by 51
Bahremand, A., Nasrabady, S. E., Shafaroodi, H., Ghasemi, M., & Dehpour, A. R. (2009) · Epilepsy Research · doi:10.1016/j.eplepsyres.2009.01.003 · Cited by 51
Antiepileptic and Prophylactic Effects of Tetrahydrocannabinols in Amygdaloid Kindled Cats*
Wada, J., Wake, A., Sato, M., & Corcoran, M. E. (1975) · Epilepsia · doi:10.1111/j.1528-1157.1975.tb06080.x · Cited by 51
Karler, R., & Turkanis, S. A. (1979) · Elsevier eBooks · doi:10.1016/b978-0-08-023759-6.50052-4 · Cited by 50
Synthetic Cannabis and Respiratory Depression
Jinwala, F., & Gupta, M. (2012) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2011.0122 · Cited by 50
Functional connectivity and cannabis use in high-risk adolescents
Houck, J. M., Bryan, A. D., & Feldstein Ewing, S. W. (2013) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2013.837914 · Cited by 50
Mortati, K. A., Dworetzky, B. A., & Devinsky, O. (2007) · PubMed · Cited by 50
Self-citationZani, A., Braida, D., Capurro, V., & Sala, M. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707514 · Cited by 47
Pant, S., Dholaria, B., Kaur, V., Ramavaram, S., Ukor, M., Deshmukh, A. J., & Teran, G. A. (2012) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31824cf5c2 · Cited by 46
Bahremand, A., Shafaroodi, H., Ghasemi, M., Nasrabady, S. E., Gholizadeh, S., & Dehpour, A. R. (2008) · Epilepsy Research · doi:10.1016/j.eplepsyres.2008.04.010 · Cited by 45
Allsop, D. J., Lintzeris, N., Copeland, J., Dunlop, A. J., & McGregor, I. S. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.109 · Cited by 44
(1989) · Epilepsia · doi:10.1111/j.1528-1157.1989.tb05321.x · Cited by 44
Vinogradova, L. V., Shatskova, A. B., & van Rijn, C. M. (2011) · Epilepsy Research · doi:10.1016/j.eplepsyres.2011.06.007 · Cited by 43
Involvement of PPAR receptors in the anticonvulsant effects of a cannabinoid agonist, WIN 55,212-2
Payandemehr, B., Ebrahimi, A., Gholizadeh, R., Rahimian, R., Varastehmoradi, B., Gooshe, M., Aghaei, H., Mousavizadeh, K., & Dehpour, A. R. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.11.005 · Cited by 42
Wada, J., Osawa, T., & Corcoran, M. E. (1975) · Epilepsia · doi:10.1111/j.1528-1157.1975.tb06071.x · Cited by 42
Hayakawa, K., Irie, K., Sano, K., Watanabe, T., Higuchi, S., Enoki, M., Nakano, T., Harada, K., Ishikane, S., Ikeda, T., et al. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.1538 · Cited by 42
The Secret “Spice”: An Undetectable Toxic Cause of Seizure
de Havenon, A., Chin, B. M., Thomas, K. C., & Afra, P. (2011) · The Neurohospitalist · doi:10.1177/1941874411417977 · Cited by 42
Romero, J., Berrendero, F., García-Gil, L., Ramos, J. A., & Fernández‐Ruíz, J. (1998) · Journal of Molecular Neuroscience · doi:10.1385/jmn:11:2:109 · Cited by 41
Gholizadeh, S., Shafaroodi, H., Ghasemi, M., Bahremand, A., Sharifzadeh, M. S., & Dehpour, A. R. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.08.005 · Cited by 41
Seizure exacerbation in two patients with focal epilepsy following marijuana cessation
Hegde, M., Santos‐Sánchez, C., Hess, C. P., Kabir, A. M. R., & Garcia, P. A. (2012) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2012.09.024 · Cited by 41
CHESHER, G. B., Jackson, D. M., & Malor, R. (1975) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1975.tb09515.x · Cited by 40
Maio, R. D., Cannon, J. R., & Greenamyre, J. T. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.10.018 · Cited by 40
Naderi, N., Ahmad-Molaei, L., Ahari, F. A., & Motamedi, F. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0479-1 · Cited by 39
Andres‐Mach, M., Żółkowska, D., Barcicka-Kłosowska, B., Haratym-Maj, A., Florek-Łuszczki, M., & Łuszczki, J. J. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.07.001 · Cited by 38
Romero, J., Fernández‐Ruíz, J., Vela, G., Ruiz‐Gayo, M., Fuentes, J. A., & Ramos, J. A. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00036-2 · Cited by 38
Łuszczki, J. J., Andres‐Mach, M., Barcicka-Kłosowska, B., Florek-Łuszczki, M., Haratym-Maj, A., & Czuczwar, S. J. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.07.001 · Cited by 38
THC:CBD Spray and MS Spasticity Symptoms: Data from Latest Studies
Rekand, T. (2014) · European Neurology · doi:10.1159/000357742 · Cited by 37
?9-tetrahydrocannabinol effect on audiogenic seizure susceptibility
Boggan, W. O., Steele, R. A., & Freedman, D. X. (1973) · Psychopharmacology · doi:10.1007/bf00422641 · Cited by 36
Raver, S. M., & Keller, A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.07.006 · Cited by 36
Loss of cholecystokinin-containing terminals in temporal lobe epilepsy
Sun, C., Sun, J., Erişir, A., & Kapur, J. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.08.018 · Cited by 36
Marijuana use and the risk of new onset seizures.
Brust, J. C. M., Ng, S. K., Hauser, A., & Susser, M. W. (1992) · PubMed · Cited by 36
Łuszczki, J. J., Czuczwar, P., Cioczek‐Czuczwar, A., Dudra-Jastrzębska, M., Andres‐Mach, M., & Czuczwar, S. J. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.09.005 · Cited by 35
Rudenko, V., Rafiuddin, A., Leheste, J. R., & Friedman, L. K. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.10.005 · Cited by 34
Mu, J., Zhuang, S.-Y., Hampson, R. E., & Deadwyler, S. A. (2000) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240050975 · Cited by 33
Çakıl, D., Yıldırım, M., Ayyıldız, M., & Ağar, E. (2010) · Epilepsy Research · doi:10.1016/j.eplepsyres.2010.11.008 · Cited by 33
Shubina, L., Алиев, Р. Р., & Kitchigina, V. F. (2015) · Epilepsy Research · doi:10.1016/j.eplepsyres.2015.01.003 · Cited by 31
Łuszczki, J. J., Właź, A., Karwan, S., Florek-Łuszczki, M., & Czuczwar, S. J. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.10.020 · Cited by 31
Deshpande, L. S., Blair, R. E., & DeLorenzo, R. J. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.02.007 · Cited by 31
Seizing an Opportunity for the Endocannabinoid System: Endocannabinoids Seizing Attention
Alger, B. E. (2014) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7597-14.5.272 · Cited by 31
Acute and chronic effects of Δ9-tetrahydrocannabinol on seizures in the gerbil
Ham, M. T., Loskota, W. J., & Lomax, P. (1975) · European Journal of Pharmacology · doi:10.1016/0014-2999(75)90087-4 · Cited by 29
Epileptiform Seizures in Domestic Fowl. V. The Anticonvulsant Activity of Δ9-Tetrahydrocannabinol
Johnson, D., McNeill, J. R., Crawford, R. D., & Wilcox, W. C. (1975) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y75-140 · Cited by 26
Florek-Łuszczki, M., Właź, A., Zagaja, M. P., Andres‐Mach, M., Kondrat-Wrobel, M. W., & Łuszczki, J. J. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.01.003 · Cited by 26
Karler, R., Calder, L. D., Sangdee, P., & Turkanis, S. A. (1984) · Neuropharmacology · doi:10.1016/0028-3908(84)90052-2 · Cited by 24
Prolonged CNS hyperexcitability in mice after a single exposure to delta-9-tetrahydrocannabinol
Karler, R., Calder, L. D., & Turkanis, S. A. (1986) · Neuropharmacology · doi:10.1016/0028-3908(86)90240-6 · Cited by 23
Differential Effects of Medical Marijuana Based on Strain and Route of Administration
Corral, V. L. (2001) · Journal of Cannabis Therapeutics · doi:10.1300/j175v01n03_05 · Cited by 22
The Development of Cannabinoid Based Therapies for Epilepsy
Hill, A. J., Hill, T. D. M., & Whalley, B. J. (2013) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781608050284113010011 · Cited by 21
Self-citationCharacterizing cannabis-induced psychosis: A study with prepulse inhibition of the startle reflex
Morales‐Muñoz, I., Barba, R. J., Ponce, G., Martínez‐Gras, I., Jiménez‐Arriero, M. Á., Moratti, S., & Rubio, G. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.08.010 · Cited by 19
Endocannabinoid system protects against cryptogenic seizures
van Rijn, C. M., Perescis Martin, F. J., Vinogradova, L. V., & van, L. G. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70411-x · Cited by 18
Sayers, K. W., Nguyen, P., Blair, R. E., Sim‐Selley, L. J., & DeLorenzo, R. J. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03460.x · Cited by 10
Endocannabinoids: Molecular, Pharmacological, Behavioral and Clinical Features
Melis, M., Muntoni, A. L., & Pistis, M. (2013) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/97816080502841130101 · Cited by 10
Cited by
The pharmacokinetics and the pharmacodynamics of cannabinoids
Lucas, C. J., Galettis, P., & Schneider, J. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13710 · Cited by 724
Cannabidiol: State of the art and new challenges for therapeutic applications
Pisanti, S., Malfitano, A. M., Ciaglia, E., Lamberti, A., Ranieri, R., Cuomo, G., Abate, M., Faggiana, G., Proto, M. C., Fiore, D., et al. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.041 · Cited by 614
Interactions between cannabidiol and commonly used antiepileptic drugs
Gaston, T. E., Bebin, E. M., Cutter, G. R., Liu, Y., Szaflarski, J. P., & Program, T. U. C. (2017) · Epilepsia · doi:10.1111/epi.13852 · Cited by 349
Abrams, D. I. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.01.003 · Cited by 296
Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals
Legare, C. A., Raup-Konsavage, W. M., & Vrana, K. E. (2022) · Pharmacology · doi:10.1159/000521683 · Cited by 275
Metadata
- Authors
- Rosenberg, E. C., Tsien, R. W., Whalley, B. J., & Devinsky, O.
- Venue
- Neurotherapeutics
- Publisher
- Elsevier BV
- Published
- 2015-10
- Volume
- 12
- Issue
- 4
- Pages
- 747-768
- ISSN
- 1878-7479 (ISSN-L)
- OpenAlex
- W1853642699
- Cited by
- 276
- References
- 324
- FWCI
- 16.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.